Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009742
Filing Date
2023-03-30
Accepted
2023-03-30 16:06:10
Documents
71
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1089487
2 ex3-2.htm EX-3.2 107659
3 ex4-1.htm EX-4.1 26045
4 ex10-20.htm EX-10.20 92567
5 ex23-1.htm EX-23.1 3045
6 ex31-1.htm EX-31.1 11398
7 ex32-1.htm EX-32.1 8029
  Complete submission text file 0001493152-23-009742.txt   5855681

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE plsh-20221231.xsd EX-101.SCH 47193
9 XBRL CALCULATION FILE plsh-20221231_cal.xml EX-101.CAL 59312
10 XBRL DEFINITION FILE plsh-20221231_def.xml EX-101.DEF 181175
11 XBRL LABEL FILE plsh-20221231_lab.xml EX-101.LAB 402548
12 XBRL PRESENTATION FILE plsh-20221231_pre.xml EX-101.PRE 305616
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 716339
Mailing Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121
Business Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121 561-455-4822
PANACEA LIFE SCIENCES HOLDINGS, INC. (Filer) CIK: 0001552189 (see all company filings)

EIN.: 271085858 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38190 | Film No.: 23780672
SIC: 2833 Medicinal Chemicals & Botanical Products